Goran
Ando, MD began his career
in the pharmaceutical industry in 1978 as Medical Director of Pfizer AB,
progressing to Director, Clinical Research with Pfizer International in
the U.S.. Dr. Ando then became VP, Medical and Scientific Affairs at
Bristol-Myers and later returned to Sweden as President of the
Astra Research Centre. Between 1989 and
1995, he held
various senior appointments at Glaxo,
including Research & Development Director for Glaxo
Group Research.
In 1995. Dr. Ando joined
Pharmacia AB in Sweden
as Executive Vice President and Deputy CEO, moving to the U.S. in 1997 to
lead R&D with additional responsibilities for manufacturing, IT,
business development and M&A. During his eight year tenure as head of R&D at
Pharmacia/Pharmacia&Upjohn, 17
NCEs were approved by the US FDA. Most
recently, Dr. Ando was CEO of Celltech, one
of the
most successful European biotech companies, until it was acquired by UCB
Pharma for $3 billion in 2005.
Dr. Ando joined Essex Woodlands in January 2007 as Senior Advisor to the
London office. He
currently resides in London although he previously lived in the U.S. for
12 years. Dr. Ando earned his Doctor of Medicine from
Linköping
University in Sweden.
|
